Deciphera Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
DCPH
CUSIP
24344T101
All holders as of
Q2 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q2 1 50.0 k $759 k
2024 Q1 187 63.1 M $993 M
2023 Q4 174 62.7 M $1.01 B
2023 Q3 164 56.6 M $720 M
2023 Q2 151 56.2 M $792 M
2023 Q1 155 58.0 M $897 M
2022 Q4 158 55.7 M $913 M
2022 Q3 159 49.1 M $909 M
2022 Q2 134 48.1 M $635 M
2022 Q1 131 43.6 M $408 M
2021 Q4 168 46.4 M $456 M
2021 Q3 183 42.7 M $1.45 B
2021 Q2 164 43.5 M $1.58 B
2021 Q1 190 43.4 M $1.94 B
2020 Q4 211 43.7 M $2.49 B
2020 Q3 184 42.7 M $2.18 B
2020 Q2 190 42.9 M $2.52 B
2020 Q1 167 40.8 M $1.68 B
2019 Q4 174 36.0 M $2.24 B
2019 Q3 138 36.0 M $1.22 B
2019 Q2 100 23.3 M $525 M
2019 Q1 83 22.6 M $524 M
2018 Q4 82 22.1 M $463 M
2018 Q3 94 21.9 M $847 M
2018 Q2 91 20.9 M $823 M
2018 Q1 56 15.6 M $313 M
2017 Q4 59 15.7 M $355 M
2017 Q3 50 14.6 M $275 M